Home » Medical Devices » Non-Opioid Pain Patch Market

Non-Opioid Pain Patch Market By Patch Type (Lidocaine Patches, Diclofenac Patches, Capsaicin Patches, Methyl Salicylate Patches), By Distribution Channel Type (Hospital Pharmacy, Retail Pharmacy/Independent Pharmacy, E-Commerce/ Online Pharmacy) – Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Price: $4999

Published: | Report ID: 14412 | Report Format : PDF

Market Insights

Pain is a symptom that fundamentally results from any injury, infection, disorder, or disease. Globally, more than 1.5 billion people suffer from different types of pain, and among all, lower back pain, neck pain, headaches, and facial pain are the most common. Unlike acute pain, which is temporary and relieved when the underlying cause is healed, chronic pain, in general, lasts for a longer period of time. Management of pain is accomplished with various treatments, including drug therapy, physical therapy, biofeedback, and others.

The non-opioid pain patch is a kind of treatment for pain relief. The pain patch, when placed on a painful area, releases its medicine content through the skin’s surface and inhibits the transfer of pain signals. The patches can be customized as per the applied area. To counteract opioid abuse, newer, innovative, and more effective non-opioid pain patches are getting developed, which in turn drive the non-opioid pain patch market’s growth.

Rising opioid abuse is a major concern, as only in the U.S., more than 20,000 deaths have been recorded resulting from an opioid overdose. Along with rising opioid abuse, the harmful side effects of opioids drive the usage of non-opioid pain patches and their market. The increasing trend of chronic pain contributes to the growth of the non-opioid pain patch market. The non-opioid pain patch market is still growing, as many of its products are under clinical trial. Teikoku Pharma USA, Inc. declared their recent innovation, a dexmedetomidine transdermal non-opioid pain patch for post-surgical pain treatment, which is still under clinical trial and expected to provide effective results in pain management. However, the lower adoption rate of non-opioid pain patches in contrast to drugs poses some challenges to the growth of the non-opioid pain patch market.

The purpose of this research study titled “Non-Opioid Pain Patch Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” is to provide investors, developers, company executives, and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global non-opioid pain patch market. This report presents and analyses the major trends prevalent in the global non-opioid pain patch market and the market size and forecast.This report categorizes the global non-opioid pain patch market in terms of patch type, distribution channel, and geographical distribution.

On the basis of patch type, the non-opioid pain patch market is classified as follows:

  • Lidocaine Patches
  • Diclofenac Patches
  • Capsaicin Patches
  • Methyl Salicylate Patches
  • Others

Based on the distribution channel, the non-opioid pain patch market is categorized as follows:

  • Hospital pharmacy
  • Retail pharmacy or independent pharmacy
  • E-commerce/online pharmacy

Each considered geographical market’s market size and forecast are presented for the period 2015-2025, along with CAGRs for the forecast period 2017-2025, and are further cross-sectionally presented in terms of patch type, distribution channel type, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global non-opioid pain patch market. Competition assessment tools such as major agreements, partnerships, and collaborations, market attractiveness assessment, and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the non-opioid pain patch market. The key players profiled in this report are The Seng Pharmaceutical Mfg. Co., Ltd., Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd., Allergan, Pfizer, Inc., Hisamitsu Pharmaceutical Co. Inc., GlaxoSmithKline plc., Mylan N.V., IBSA Institut Biochimique SA, Inc., Acorda Therapeutics, and othersTransdermal drug delivery is the best alternative to oral drug delivery. This non-invasive procedure provides a better patient outcome with fewer adverse effects.

Based on the type of patches, the non-opioid pain patch market has been categorized as follows:

  • Lidocaine Patches
  • Diclofenac Patches
  • Capsaicin Patches
  • Methyl Salicylate Patches
  • Others

A lidocaine patch is a non-opioid that is applied to healthy skin. This patch is used to treat neuropathic pain, generally from post-herpetic neuralgia, and it is also useful for the treatment of diabetic neuropathy or HIV-related neuropathy. Lidoderm was the first Lidocaine patch to receive FDA approval. The lidocaine patch market is expected to be the largest and is estimated to grow more in the near future. The safety, fewer risks, and lesser chances of side effects contribute to the growth of its market.

A methyl salicylate patch is used to treat the pain caused by arthritis, strains, or sprains. Salonpas is the first and only FDA-approved over-the-counter methyl salicylate pain patch. Capsaicin patches help to resolve muscle or joint pains, and Diclofenac patches work by blocking the pain-producing agent for the treatment of pain from minor strains, bruises, or injuries.

Although there are some adverse effects associated with non-opioid patches like allergic reactions, hives, redness, blisters, shortness of breath, etc., the benefits of customization of patches, easy administration, fewer doses, and better patient outcomes contribute to the growth of the non-opioid pain patch market.

Depending on the distribution channel, the non-opioid pain patch market is segmented into the following categories:

  • Hospital pharmacy
  • Retail pharmacy or independent pharmacy
  • E-commerce/Online Pharmacy

The hospital pharmacy is predicted to contribute to the maximum growth of the non-opioid pain patch market, whereas the retail pharmacy and e-commerce are expected to face major growth in the forecasting years due to extensive discounting and easy availability of products. In the case of online pharmacies, the option of free delivery attracts the public’s attention, resulting in expected profitable growth in the coming years.

The global non-opioid pain patch market is divided into five regions: North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America.North America is anticipated to dominate the non-opioid pain patch market, followed by Europe. According to a study by the National Institutes of Health’s National Center for Complementary and Integrative Health (NCCIH), more than 50 million people in America suffer from chronic pain. Pain is a serious health issue globally, for which $560–635 billion USD is spent annually on treatment only in the U.S. This rising incidence of severe pain, combined with increased public awareness of health issues, contributes to North America’s dominance. More than 2 million people have substance abuse disorders using prescription opioids, and around 20,000 people died from opioid overdoses in 2015.

This rate of opioid abuse shifts the trend of pain management towards non-opioid patches. Research on innovative and effective product development for pain management drives the non-opioid pain patch market in North America and Europe. The prevalence of post-herpetic neuralgia in the United States is estimated to be around 144,000, and the associated pain is difficult to treat with oral medications, driving increased use of the Lidocaine patch and fueling its growth. The huge number of people suffering from pain disorders, developing healthcare infrastructure, and cost-effectiveness fuel the growth of the non-opioid pain patch market in the Asia-Pacific region, and it is expected to face substantial growth in upcoming periods due to the growing trend of health awareness in public.

The detailed regional classification of the global non-opioid pain patch market is as follows:

  • North America (U.S. and Canada)
  • Europe (Germany, U.K., France, Spain, Italy, and the Rest of Europe)
  • Asia Pacific (China, India, Japan, and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East and Africa (including the Gulf Cooperation Council and the rest of the Middle East and Africa)

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Non-Opioid Pain Patch Market Portraiture
2.2 Non-Opioid Pain Patch Market, by Patch Type, 2016 (US$ Mn)
2.3 Non-Opioid Pain Patch Market, by Distribution Channel Type, 2016 (US$ Mn)
2.4 Non-Opioid Pain Patch Market, by Geography, 2016 (Value %)

Chapter 3 Global Non-Opioid Pain Patch Market Analysis
3.1 Global Non-Opioid Pain Patch Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Analysis: Global Non-Opioid Pain Patch Market, 2016 (Value %)

Chapter 4 Global Non-Opioid Pain Patch Market Analysis, By Patch
Type
4.1 Overview
4.1.1 Market Attractive Proposition of Non-Opioid Pain Patch Market, by Patch
Type, 2016
4.2 Lidocaine Patches
4.3 Diclofenac Patches
4.4 Capsaicin Patches
4.5 Methyl Salicylate Patches
4.6 Others

Chapter 5 Global Non-Opioid Pain Patch Market Analysis, By
Distribution Channel Type
5.1 Overview
5.1.1 Market Attractive Proposition of Non-Opioid Pain Patch Market, by
Distribution Channel Type, 2016
5.2 Hospital Pharmacy
5.3 Retail Pharmacy/Independent Pharmacy
5.4 E-commerce/ Online Pharmacy

Chapter 6 Global Non-Opioid Pain Patch Market Analysis, By
Geography
6.1 Preface
6.2 North America (U.S. & Canada)
6.2.1 North America Non-Opioid Pain Patch Market, by Patch Type, 2015-2025 (US$ Mn)
6.2.2 North America Non-Opioid Pain Patch Market, by Distribution Channel
Type, 2015-2025 (US$ Mn)
6.2.3 North America Non-Opioid Pain Patch Market, by Country, 2015 – 2025 (US$ Mn)
6.3 Europe (U.K., Germany & Rest of Europe)
6.3.1 Europe Non-Opioid Pain Patch Market, by Patch Type, 2015-2025 (US$ Mn)
6.3.2 Europe Non-Opioid Pain Patch Market, by Distribution Channel Type,
2015-2025 (US$ Mn)
6.3.3 Europe Non-Opioid Pain Patch Market, by Country, 2015 – 2025 (US$ Mn)
6.4 Asia-Pacific (China, Japan & Rest of Asia-Pacific)
6.4.1 Asia Pacific Non-Opioid Pain Patch Market, by Patch Type, 2015-2025 (US$ Mn)
6.4.2 Asia Pacific Non-Opioid Pain Patch Market, by Distribution Channel Type,
2015-2025 (US$ Mn)
6.4.3 Asia – Pacific Non-Opioid Pain Patch Market, by Country, 2015 – 2025 (US$ Mn)
6.5 Latin America (Brazil, Mexico and Rest of LATAM)
6.5.1 Latin America Non-Opioid Pain Patch Market, by Patch Type, 2015-2025 (US$ Mn)
6.5.2 Latin America Non-Opioid Pain Patch Market, by Distribution Channel
Type, 2015-2025 (US$ Mn)
6.5.3 Latin America Non-Opioid Pain Patch Market, by Country, 2015 – 2025 (US$ Mn)
6.6 Middle East and Africa
6.6.1 Middle East and Africa Non-Opioid Pain Patch Market, by Patch Type,
2015-2025 (US$ Mn)
6.6.2 Middle East and Africa Non-Opioid Pain Patch Market, by Distribution
Channel Type, 2015-2025 (US$ Mn)
6.6.3 Middle East and Africa Non-Opioid Pain Patch Market, by Country, 2015 –
2025 (US$ Mn)

Chapter 7 Company Profiles
7.1 Teh Seng Pharmaceutical Mfg. Co., Ltd.
7.2 Endo Pharmaceuticals Inc.
7.3 Teikoku Seiyaku Co.
7.4 Allergan
7.5 Pfizer, Inc.
7.6 Hisamitsu Pharmaceutical Co. Inc.
7.7 GlaxoSmithKline plc.
7.8 Mylan N.V.
7.9 IBSA Institut Biochimque SA, Inc.
7.10 Acorda Therapeutics
7.11 Others

 

List of Figures

FIG. 1 Non-Opioid Pain Patch Treatment Market: Research Methodology
FIG. 2 Non-Opioid Pain Patch Market, by Patch Type, 2016 (US$ Mn)
FIG. 3 Non-Opioid Pain Patch Market, by Distribution Channel Type, 2016 (US$ Mn)
FIG. 4 Non-Opioid Pain Patch Market, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition
FIG. 6 Competitive Analysis: Global Non-Opioid Pain Patch Market, 2016 (Value %)

List of Tables

TABLE 1 Global Non-Opioid Pain Patch Market, By Patch Type (US$ Mn), 2015– 2025 (Value)
TABLE 2 Global Lidocaine Patches Market (US$ Mn), 2015-2025
TABLE 3 Global Diclofenac Patches Market (US$ Mn), 2015-2025
TABLE 4 Global Capsaicin Patches Market (US$ Mn), 2015-2025
TABLE 5 Global Methyl Salicylate Patches Market (US$ Mn), 2015-2025
TABLE 6 Global Others Market (US$ Mn), 2015-2025
TABLE 7 Global Non-Opioid Pain Patch Market, By Distribution Channel Type (US$ Mn), 2015–2025 (Value)
TABLE 8 Global Hospital Pharmacy Market (US$ Mn), 2015-2025
TABLE 9 Global Retail Pharmacy/Independent Pharmacy Market (US$ Mn), 2015-2025
TABLE 10 Global E-commerce/ Online Pharmacy Market (US$ Mn), 2015-2025
TABLE 11 Global Non-Opioid Pain Patch Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 12 North America Non-Opioid Pain Patch Market, by Patch Type, 2015 – 2025 (US$ Mn)
TABLE 13 North America Non-Opioid Pain Patch Market, by Distribution Channel Type, 2015 – 2025 (US$ Mn)
TABLE 14 North America Non-Opioid Pain Patch Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 15 Europe Non-Opioid Pain Patch Market, by Patch Type, 2015 – 2025 (US$ Mn)
TABLE 16 Europe Non-Opioid Pain Patch Market, by Distribution Channel Type, 2015 – 2025 (US$ Mn)
TABLE 17 Europe Non-Opioid Pain Patch Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 18 Asia Pacific Non-Opioid Pain Patch Market, by Patch Type, 2015 – 2025 (US$ Mn)
TABLE 19 Asia Pacific Non-Opioid Pain Patch Market, by Distribution Channel Type, 2015 – 2025(US$ Mn)
TABLE 20 Asia – Pacific Non-Opioid Pain Patch Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 21 Latin America Non-Opioid Pain Patch Market, by Patch Type, 2015 – 2025 (US$ Mn)
TABLE 22 Latin America Non-Opioid Pain Patch Market, by Distribution Channel Type, 2015 – 2025 (US$ Mn)
TABLE 23 Latin America Non-Opioid Pain Patch Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 24 Middle East and Africa Non-Opioid Pain Patch Market, by Patch Type, 2015 – 2025 (US$ Mn)
TABLE 25 Middle East and Africa Non-Opioid Pain Patch Market, by Distribution Channel Type,2015 – 2025 (US$ Mn)
TABLE 26 Middle East and Africa Non-Opioid Pain Patch Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 27 Teh Seng Pharmaceutical Mfg. Co., Ltd.: Company Snapshot (Business Description;Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 28 Endo Pharmaceuticals Inc.: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
TABLE 29 Teikoku Seiyaku Co.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 30 Allergan: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 31 Pfizer, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 32 Hisamitsu Pharmaceutical Co. Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 33 GlaxoSmithKline plc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 34 Mylan N.V.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 35 IBSA Institut Biochimque SA, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 36 Acorda Therapeutics: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)
TABLE 37 Others: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage)

Frequently Asked Questions:

What is the size of Non-Opioid Pain Patch Market?

The market for Non-Opioid Pain Patch Market is expected to reach US$ 5.0 Bn By 2025.

What is the Non-Opioid Pain Patch Market CAGR?

The Non-Opioid Pain Patch Market is expected to see significant CAGR growth over the coming years, at 3.5%.

What is the Forecast period considered for Non-Opioid Pain Patch Market?

The report is forecasted from 2017-2025.

What is the base year considered for Non-Opioid Pain Patch Market?

The base year of this report is 2016.

Who are the major players in this market?

The Seng Pharmaceutical Mfg. Co., Ltd., Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd., Allergan, Pfizer, Inc., Hisamitsu Pharmaceutical Co. Inc., GlaxoSmithKline plc., Mylan N.V., IBSA Institut Biochimique SA, Inc. are some of the major players in the global market.

United States Ventilator Market

Published:
Report ID: 36387

United States Bariatric Surgery Devices Market

Published:
Report ID: 36381

Ventilator Market

Published:
Report ID: 36256

Endodontic Reparative Cement Market

Published:
Report ID: 36240

United States Scalp Cooling System Market

Published:
Report ID: 36100

Japan Compression Socks Market

Published:
Report ID: 36024

Chromatography Syringes Market

Published:
Report ID: 36008

Gas Chromatography Market

Published:
Report ID: 36002

Cerebral Angiography Market

Published:
Report ID: 35929

Asia Pacific Cosmetic Surgery Market

Published:
Report ID: 35562

Drug Delivery Technologies Market

Published:
Report ID: 5510

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN